Abstract
Nonischemic ST‐segment elevation may be confused as acute ST‐elevation myocardial infarction (STEMI), especially in patients with atypical presenting symptoms. Among the possible differential diagnosis, hypertrophic cardiomyopathy (HCM) should be considered. Mid‐ventricular obstructive hypertrophic cardiomyopathy (MVOHCM) is a rare type of cardiomyopathy, accounting for approximately 5% of all HCM cases. ST‐segment elevation on electrocardiogram (ECG) in patients with MVOHCM is a rare clinical presentation. We present a case of MVOHCM and apical aneurysm mimicking acute STEMI
Keywords: hypertrophic cardiomyopathy, aneurysm, myocardial infarction
ST‐segment elevation on electrocardiogram (ECG) is considered to reflect acute transmural ischemia due to acute epicardial coronary artery occlusion by thrombosis formation and commonly used to diagnose acute ST‐elevation myocardial infarction (STEMI). Nonischemic ST‐segment elevation on ECG may be confused as STEMI, especially in patients with atypical presenting symptoms. Among the possible differential diagnosis, hypertrophic cardiomyopathy (HCM) should be considered.1 Mid‐ventricular obstructive hypertrophic cardiomyopathy (MVOHCM) is a rare type of cardiomyopathy, accounting for approximately 5% of all HCM cases.2 ST‐segment elevation on ECG in patients with MVOHCM is a rare clinical presentation. We present a case of MVOHCM and apical aneurysm mimicking acute STEMI.
A 66‐year‐old female was admitted with suspected acute coronary syndrome, primarily because of pronounced ST‐segment elevations in the inferior and precordial leads. She has experienced shortness of breath and chest distress for several years, the day before admission she felt aggravated chest discomfort. She had a history of cerebral infarction for 20 years. She had no history of diabetes, hypertension, or family members with sudden cardiac death and denied alcoholism or drug abuse.
The patient's initial vital signs included heart rate 74 bpm, blood pressure 140/80 mmHg, temperature 97.7 °F (36.5 °C), and oxygen saturation 99% on room air. Cardiac auscultation revealed a normal S1 and S2 and a grade 2/6 systolic murmur at the apex. The patient's lung and abdominal examination was unremarkable. Electrocardiogram at admission revealed normal sinus rhythm and left ventricular hypertrophy by voltage criteria, There was convex ST‐segment elevation in I, II, III, aVF and V2–V6 leads followed by T‐wave inversion (dome shaped), and abnormal Q waves were not observed (Fig. 1). No previous ECGs were available for comparison. Emergent transthoracic echocardiogram showed a significant asymmetric hypertrophy of mid‐left ventricle. The maximal wall thickness of left ventricle was 22.6 mm and the hypertrophy was localized to the left anterior‐medial septum, there was a high early systolic peak flow velocity greater than 3.77 m/s in mid‐left ventricle with a high intraventricular pressure gradient 57 mm Hg across the obstruction. There were normal pressure gradient and flow velocity across the left ventricular outflow tract. Although the global left ventricular ejection fraction was not markedly impaired (left ventricular ejection fraction = 60%), aneurysm formation was observed at the left ventricular apex (26.4 × 27.2 mm). (Fig. 2, Video 1). Laboratory tests yielded a normal platelet count and coagulation profile. The cardiac troponin I was 0.048 ng/mL at admission and 0.047 ng/mL 12 hours later (normal <0.02 ng/mL) and B‐type natriuretic peptide was 508 pg/mL (normal <200 pg/mL).
Based on the patient’s ECG and echocardiogram findings, the ST‐segment elevation was considered related to MVOHCM‐associated apical aneurysm. The patient was not transferred directly to the cardiac catheterization and instead was treated with optimal medical therapy (aspirin, β‐blocker). She was followed as an outpatient for 6 months and remained clinically stable. Her follow‐up ECG at 6‐month is similar to the presenting ECG.
HCM is a genetic cardiac disease characterized by asymmetrical septal hypertrophy. Approximately 5% of HCM patients present with mid‐ventricular obstruction. Several studies have shown the potential association between mid‐ventricular HCM and apical aneurysm formation.3, 4, 5 Maron et al. showed that the prevalence of left ventricular apical aneurysm (LVAA) in all non‐Japanese HCM case was 2.2%.6 MVOHCM accompanied by apical aneurysm may increase the risk of lethal arrhythmia, thromboembolic stroke, progressive heart failure, even sudden cardiac death.7, 8, 9, 10 However, de Gregorio et al. recognized it was a benign remodeling trend because average progression rate of the apical pouch was 3.9% per year during 14‐year echocardiogram follow‐up.11
Echocardiogram is an important noninvasive tool to identify and perform risk stratification of the patients with HCM. In the present case, the echocardiogram reveals the hypertrophy in the mid portion of the left ventricle and formation of apical aneurysm. Continuous‐wave Doppler shows high flow velocity with high pressure gradient cross the mid‐left ventricle (Video 1). Although the pathogenesis of apical aneurysm in the setting of MVOHCM is not fully understood, the pressure gradient between the apex and the mid‐ventricular may be one important reason. In the present case, the pressure gradient was close to 60 mmHg. The pressure overload on the apical wall, relatively narrowing of the small intramyocardial coronary arteries, decreased coronary perfusion pressure, oxygen supply/demand mismatch, and decreased capillary myocardial fiber ratio due to mid‐ventricular obstruction might eventually lead to myocardial dysfunction and apical aneurysm formation.12, 13
Most commonly ECG abnormalities of MVOHCM included abnormal Q waves, ST‐segment depressions with T‐wave inversions and left ventricular hypertrophy by voltage criteria, In contrast, ST‐segment elevation is a rare finding in patients with MVOHCM. Ichida et al.14 showed that the ST‐segment elevation in V3–V5 on ECG is a useful marker for the early detection of LVAA formation in hypertrophic cardiomyopathy patients, the sensitivity was 66.7% (14/21), and the specificity was 98.7% (223/226).
REFERENCES
- 1. Deshpande A, Birnbaum Y. ST‐segment elevation: Distinguishing ST elevation myocardial infarction from ST elevation secondary to nonischemic etiologies. World J Cardiol 2014;6:1067–1079. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Gao XJ, Kang LM, Zhang J, et al. Mid‐ventricular obstructive hypertrophic cardiomyopathy with apical aneurysm and sustained ventricular tachycardia: A case report and literature review. Chin Med J 2011;124:1754–1757. [PubMed] [Google Scholar]
- 3. Cianciulli TF, Saccheri MC, Konopka IV, et al. Subaortic and mid‐ventricular obstructive hypertrophic cardiomyopathy with an apical Aneurysm: A case report. Cardiovasc Ultrasound 2006;4:15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Sun JP, Yang XS, Wong KT, et al. Hypertrophic cardiomyopathy with apical aneurysm. Int J Cardiol 2015;184C:394–396. [DOI] [PubMed] [Google Scholar]
- 5. Kiyooka T, Satoh Y. Mid‐ventricular obstructive hypertrophic cardiomyopathy with an apical aneurysm caused by vasospastic angina. Tokai J Exp Clin Med 2014;39:29–33. [PubMed] [Google Scholar]
- 6. Maron MS, Finley JJ, Bos JM, et al. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation 2008;118:1541–1549. [DOI] [PubMed] [Google Scholar]
- 7. Mörner S, Johansson B, Henein M. Arrhythmogenic left ventricular apical aneurysm in hypertrophic cardiomyopathy. Int J Cardiol 2011;151:e8–e9. [DOI] [PubMed] [Google Scholar]
- 8. Minami Y, Kajimoto K, Terajima Y, et al. Clinical implications of midventricularde obstruction in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2011;57:2346–2355. [DOI] [PubMed] [Google Scholar]
- 9. Kaku B. Intra‐cardiac thrombus resolution after anti‐coagulation therapy with dabigatran in a patient with mid‐ventricular obstructive hypertrophic cardiomyopathy: A case report. J Med Case Rep 2013;7:238. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Holloway CJ, Betts TR, Neubauer S, et al. Hypertrophic cardiomyopathy complicated by large apical aneurysm and thrombus, presenting as ventricular tachycardia. J Am Coll Cardiol 2010;56:1961. [DOI] [PubMed] [Google Scholar]
- 11. de Gregorio C, Andò G, Pugliatti P, et al. Progression rates of apical aneurysm and dynamic obstruction in mid‐ventricular hypertrophic cardiomyopathy: Can we recognize a ’benign trend’? Int J Cardiol 2014;182C:491–493. [DOI] [PubMed] [Google Scholar]
- 12. Kawasaki T, Sugihara H. Subendocardial ischemia in hypertrophic cardiomyopathy. J Cardiol 2014;63:89–94. [DOI] [PubMed] [Google Scholar]
- 13. Hanaoka Y, Misumi I, Rokutanda T, et al. Simultaneous pressure recording in mid‐ventricular obstructive hypertrophic cardiomyopathy. Intern Med 2012;51:387–390. [DOI] [PubMed] [Google Scholar]
- 14. Ichida M, Nishimura Y, Kario K. Clinical significance of left ventricular apical aneurysms in hypertrophic cardiomyopathy patients: the role of diagnostic electrocardiography. J Cardiol 2014;64:265–272. [DOI] [PubMed] [Google Scholar]